VASTAREL 35 mg, modified-release film-coated tablet 100 tablets
Brand page: Vastarel (trimetazidine) — all forms and strengths in France
Active ingredients: Trimetazidine dihydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Modified-release film-coated tablet100 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VASTAREL 35 mg, comprimé pelliculé à libération modifiée
- Pharmaceutical form
- comprimé pelliculé à libération modifiée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium de 100 comprimé(s)
- Marketing authorisation holder
- LES LABORATOIRES SERVIER
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Jul 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62611660CIP73572470CIP133400935724700Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DICHLORHYDRATE DE TRIMÉTAZIDINEcomprimé | 35 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.